The Valley Desk

NCT07421167 · Interventional trial

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

Overall registry status Recruiting

Phase 2

Conditions Primary Evans Syndrome (ES), Primary Immune Thrombocytopenia (ITP)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov